Skip to main content
SpringerLink
Log in

Metforminassoziierte Laktatazidose (MALA) – eine fallbasierte Darstellung

Metformin-associated lactic acidosis (MALA)—a case-based description

  • Fallbericht
  • Published:
Journal für Klinische Endokrinologie und Stoffwechsel Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Kajbaf F, Lalau JD (2013) The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. BMC Pharmacol Toxicol 14:22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chang CT, Chen YC, Fang JT, Huang CC (2002) Metformin-associated lactic acidosis: case reports and literature review. J Nephrol 15:398–402

    PubMed  Google Scholar 

  3. Leverve XM, Guigas B, Detaille D, Batandier C, Koceir EA, Chauvin C, Fontaine E, Wiernsperger NF (2003) Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab 29:6S88–6S94

    Article  CAS  PubMed  Google Scholar 

  4. Dykens JA, Jamieson J, Marroquin L, Nadanaciva S, Billis PA, Will Y (2008) Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 233:203–210

    Article  CAS  PubMed  Google Scholar 

  5. Caton PW, Nayuni NK, Kieswich J, Khan NQ, Yaqoob MM, Corder R (2010) Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol 205:97–106

    Article  CAS  PubMed  Google Scholar 

  6. Mariano F, Pozzato M, Inguaggiato P et al (2017) Metformin-associated lactic acidosis undergoing renal replacement therapy in intensive care units: a five-million population-based study in the north-west of Italy. Blood Purif 44:198–205

    Article  CAS  PubMed  Google Scholar 

  7. Haloob I, de Zoysa JR (2016) Metformin associated lactic acidosis in Auckland city hospital 2005 to 2009. World J Nephrol 5:367–371

    Article  PubMed  PubMed Central  Google Scholar 

  8. van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ (2011) Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther 36:376–382

    Article  CAS  PubMed  Google Scholar 

  9. Luft D, Deichsel G, Schmulling RM, Stein W, Eggstein M (1983) Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 80:484–489

    Article  CAS  PubMed  Google Scholar 

  10. Umeda T, Minami T, Bartolomei K, Summerhill E (2018) Metformin-associated lactic acidosis: a case report. Drug Saf Case Rep 5:8

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053

    Article  PubMed  Google Scholar 

  12. [No authors listed] (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854–865

  13. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G (2013) Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 1(Suppl):45–49

    Google Scholar 

  14. Kuo CC, Yeh HC, Chen B, Tsai CW, Lin YS, Huang CC (2015) Prevalence of metformin use and the associated risk of metabolic acidosis in US diabetic adults with CKD: a national cross-sectional study. Medicine (Baltimore) 94:e2175

    Article  CAS  Google Scholar 

  15. Cohen RD, Woods HF (1976) Clinical and biochemical aspects of lactic acidosis. Melbourn blackwell scientific Publications, Oxford, London, Edinburgh

    Google Scholar 

  16. Gelaye A, Haidar A, Kassab C et al (2016) Severe Ketoacidosis associated with Canagliflozin (Invokana): a safety concern. Case Rep Crit Care. https://doi.org/10.1155/2016/1656182

    Article  PubMed  PubMed Central  Google Scholar 

  17. Protti A, Fortunato F, Monti M et al (2012) Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs. Crit Care 16(3):R75

    Article  PubMed  PubMed Central  Google Scholar 

  18. Daul K, Kribben A, Daul A (2016) [P012] bedeutung von Metformin als kausaler Faktor einer Metformin-assoziierten laktatazidose Konsequenzen für diagnostik, therapie und Prävention. Internist 57(Suppl 1):S12–S13

    Google Scholar 

  19. Andrzejewski S, Gravel SP, Pollak M, St-Pierre J (2014) Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab 2:12

    Article  PubMed  PubMed Central  Google Scholar 

  20. Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542–546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sheen AJ (1996) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 30:359–371

    Article  Google Scholar 

  22. Yeh H‑C, Ting I‑W, Tsai C‑W, Wu J‑Y, Kuo C‑C (2017) Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series. BMC Nephrol 18:229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lalau JD, Race JM (1999) Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 20:377–384

    Article  CAS  PubMed  Google Scholar 

  24. Lalau JD, Race JM (1999) Lactic acidosis in metformin therapy. Drugs 58:55–60

    Article  CAS  PubMed  Google Scholar 

  25. Dell’Aglio DM, Perino LJ, Kazzi Z, Abramson J, Schwartz MD, Morgan BW (2009) Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 54:818–823

    Article  PubMed  Google Scholar 

  26. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  CAS  PubMed  Google Scholar 

  27. Lalau JD, Race JM (1999) Lactic acidosis in metformintreated patients. Drug Saf 20:377–384

    Article  CAS  PubMed  Google Scholar 

  28. Almirall J, Bricullé M, Gonzalez-Clemente JM (2008) Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice. Nephrol Dial Transplant 23:2436–2438

    Article  CAS  PubMed  Google Scholar 

  29. Boucaud-Maitre D, Ropers J, Porokhov B, Altman JJ, Bouhanick B, Doucet J, Girardin E, Kaloustian E, Lassmann Vague V, Emmerich J (2016) Lactic acidosis: relationship between metformin levels, lactate concentration and mortality. Diabet Med 33:1536–1543

    Article  CAS  PubMed  Google Scholar 

  30. Pan LT, Maclaren G (2009) Continuous veno-venous haemodiafiltration for metformin-induced lactic acacidosis. Anaesth Intensive Care 37:830–832

    CAS  PubMed  Google Scholar 

  31. Nguyen HL, Concepcion L (2011) Metformin intoxication requiring dialysis. Hemodial Int 15:68–71

    Article  Google Scholar 

  32. Mariano F, Benzi L, Cecchetti P, Rosatello A, Merante D, Goia F, Capra L, Lanza G, Curto V, Cavalli PL (1998) Efficacy of continuous venovenous haemofiltration (CVVH) in the treatment of severe phenformin-induced lactic acidosis. Nephrol Dial Transplant 13:1012–1015

    Article  CAS  PubMed  Google Scholar 

  33. Arroyo AM, Walroth TA, Mowry JB, Kao LW (2010) The MALAdy of metformin poisoning: is CVVH the cure? Am J Ther 17:96–100

    Article  PubMed  Google Scholar 

  34. Keller G, Cour M, Hernu R, Illinger J, Robert D, Argaud L (2011) Management of metformin-associated lactic acidosis by continuous renal replacement therapy. PLoS ONE 6:e23200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Abteilung, LKH Südsteiermark Standort Wagna, Wagna, Österreich

    D. Parcz

Authors
  1. A. Polach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Parcz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Parcz.

Ethics declarations

Interessenkonflikt

A. Polach, D. Parcz und B. Ritter geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Polach, A., Parcz, D. & Ritter, B. Metforminassoziierte Laktatazidose (MALA) – eine fallbasierte Darstellung. J. Klin. Endokrinol. Stoffw. 11, 127–130 (2018). https://doi.org/10.1007/s41969-018-0048-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41969-018-0048-1

Search

Navigation